Philips introduces InkSpace Imaging's Snuggle(TM) flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort
MWN-AI** Summary
On February 12, 2026, Royal Philips (NYSE: PHG, AEX: PHIA), a leading global health technology company, announced the launch of the InkSpace Imaging Snuggle™ pediatric body array coil, specifically designed for its 3.0T MRI systems. This innovative product targets the unique challenges faced by pediatric patients during MRI examinations, enhancing both comfort and imaging quality.
The Snuggle coil features a lightweight, blanket-like structure that gently envelops young patients, significantly reducing the intimidating aspect of MRI scans. Its flexible design accommodates various pediatric anatomies, allowing for high-density imaging that produces sharp, high-resolution results. This capability not only improves the efficiency of the imaging process but also minimizes the necessity for follow-up imaging, thereby streamlining the workflow for technologists through easier handling and shorter setup times.
Ioannis Panagiotelis, Business Leader at Philips MR, emphasized the collaborative effort behind the Snuggle coil, which merges Philips's expertise in MRI technology with InkSpace Imaging's focus on child-centric design. This partnership aims to mitigate the stress associated with MRI scans for children while ensuring that clinicians receive the high-quality images they depend on.
The product recently received FDA clearance through the 510(k) process, highlighting its commitment to safety and performance tailored for pediatric needs. Dr. Peter Fischer, CEO of InkSpace Imaging, expressed optimism about its potential, stating that the Snuggle coil addresses specific challenges without compromising comfort or imaging quality.
Currently available in the United States, Philips plans to roll out the Snuggle coil to additional regions in the near future. Both Philips and InkSpace Imaging are committed to further developing innovations that enhance the experience of pediatric MRI examinations for patients and healthcare providers alike.
MWN-AI** Analysis
Philips’ recent launch of the InkSpace Imaging Snuggle™ pediatric MRI coil presents a significant advancement in the radiology market, particularly in pediatric imaging. As a financial analyst, investors should consider grasping the strategic implications of this innovation within the healthcare technology sector.
The Snuggle coil's unique design—emphasizing both comfort for pediatric patients and high-resolution imaging—enhances the overall value proposition for healthcare providers. This innovation aligns with the growing trend of patient-centered care and offers significant benefits in reducing the need for repeat imaging due to enhanced precision. The long-term effects of such technologies can lead to increased operational efficiencies for hospitals, which may translate to cost savings.
Market response to such innovations can often influence share price positively, especially given that the Snuggle coil has already garnered FDA clearance. This can serve as an endorsement of Philips' commitment to quality and innovation—key factors that investors look for. Increased adoption of this technology can lead to higher sales volumes, supporting revenue growth for Philips in the imaging segment.
Moreover, as healthcare systems globally shift towards prioritizing comfort alongside clinical accuracy, Philips’ strategic positioning with the Snuggle coil can enhance its market share. The potential rollout to other regions further opens avenues for revenue expansion.
However, investors should also monitor potential competitive responses from other players in the healthcare technology space who might seek to replicate or counter Philips' advancements. Additionally, observing regulatory developments and shifts in pediatric imaging demands will be crucial in assessing the future performance of Philips.
In conclusion, Philips’ introduction of the Snuggle pediatric coil marks a critical development in healthcare imaging technology, promising both clinical and operational advantages, while potentially benefiting investors as the company solidifies its market position.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
February 12, 2026
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric body array coil for Philips 3.0T MRI systems. Designed specifically for pediatric patients, the Snuggle coil has been optimized and validated for use with Philips 3.0T MRI systems, bringing enhanced comfort for children and efficient, high-quality imaging for clinicians.
Young patients often find MRI exams challenging, and the Snuggle™ coil was created to make the experience more comfortable and less intimidating. Its light, blanket-like design and soft, flexible structure gently wrap around the patient.
The Snuggle coil’s high-density array and flexible design allow sharp, high-resolution images and more efficient exams across a range of pediatric anatomies. These advantages can reduce the need for additional imaging or follow-up procedures while helping technologists work more efficiently through easier handling, faster setup and shorter scan times, helping to improve throughput and reduce repeat exams.
“This collaboration combines Philips MRI leadership with InkSpace Imaging’s focus on pediatric design,” said Ioannis Panagiotelis, PhD, Business Leader, MR at Philips. “The Snuggle coil shows how thoughtful design can make MRI scans less stressful for children while giving clinicians the image quality and workflow efficiency they rely on.”
Recently cleared through the U.S. Food and Drug Administration (FDA) 510(k) process, InkSpace Imaging developed the Snuggle coil to provide a more child-friendly alternative to traditional rigid devices.
“Snuggle was designed and built by InkSpace Imaging to solve a very specific pediatric challenge: comfort and performance without tradeoffs,” said Dr. Peter Fischer, CEO, InkSpace Imaging. “By enabling compatibility with Philips 3.0T MRI systems, we can bring that child-centered design to more hospitals and help care teams get the scan right the first time.”
The Snuggle pediatric coil for Philips 3.0T MR systems is now available in the United States, with rollout to additional regions planned in the future. Philips and InkSpace Imaging continue to explore opportunities to expand comfort- and efficiency-focused coil technology, supporting radiologists, technologists, and families with safer, faster, and more effective MRI exams.
For further information, please contact:
Jayme Maniatis
Philips Global External Relations
Tel.: +1 416 270 6757
E-mail: [email protected]
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2025 sales of EUR 18 billion and employs approximately 64,800 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachments
- Designed for Pediatric Comfort
- Flexible, High Density Coil Design
- Child Centered Innovation for 3.0T MRI
FAQ**
How does the new Snuggle™ coil by Koninklijke Philips NV RYLPF enhance imaging efficiency and comfort for pediatric patients compared to traditional MRI coils?
What impact do you anticipate the rollout of the Snuggle™ coil by Koninklijke Philips NV RYLPF will have on the overall patient experience in hospitals?
Considering the recent FDA clearance, how does Koninklijke Philips NV RYLPF plan to market the Snuggle™ coil within the U.S. healthcare system?
As Koninklijke Philips NV RYLPF and InkSpace Imaging explore expansion opportunities, what future innovations can we expect in pediatric imaging technology?
**MWN-AI FAQ is based on asking OpenAI questions about Koninklijke Philips NV (OTC: RYLPF).
NASDAQ: RYLPF
RYLPF Trading
0.0% G/L:
$31.748 Last:
164 Volume:
$31.748 Open:
